目前开发富血小板血浆疗法所面临的挑战。

IF 2.6 3区生物学 Q3 BIOTECHNOLOGY & APPLIED MICROBIOLOGY

BioMed Research International Pub Date : 2024-08-09 eCollection Date: 2024-01-01 DOI:10.1155/2024/6444120

Jon Mercader-Ruiz, Maider Beitia, Diego Delgado, Pello Sánchez, Begoña Porras, Irene Gimeno, Sergio González, Fernando Benito-Lopez, Lourdes Basabe-Desmonts, Mikel Sánchez

{"title":"目前开发富血小板血浆疗法所面临的挑战。","authors":"Jon Mercader-Ruiz, Maider Beitia, Diego Delgado, Pello Sánchez, Begoña Porras, Irene Gimeno, Sergio González, Fernando Benito-Lopez, Lourdes Basabe-Desmonts, Mikel Sánchez","doi":"10.1155/2024/6444120","DOIUrl":null,"url":null,"abstract":"Nowadays, biological therapies are booming and more of these formulations are coming to the market. Platelet-rich plasma, or PRP, is one of the most widely used biological therapies due to its ease of obtention and autologous character. Most of the techniques to obtain PRP are focusing on new processes and methods of optimization. However, not enough consideration is being given to modify the molecular components of PRP to generate more effective formulations with the aim of improving PRP treatments. Therefore, this review covers different novel PRP-obtaining methods that attempt to modify the molecular composition of the plasma.","PeriodicalId":9007,"journal":{"name":"BioMed Research International","volume":"2024 ","pages":"6444120"},"PeriodicalIF":2.6000,"publicationDate":"2024-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11329313/pdf/","citationCount":"0","resultStr":"{\"title\":\"Current Challenges in the Development of Platelet-Rich Plasma-Based Therapies.\",\"authors\":\"Jon Mercader-Ruiz, Maider Beitia, Diego Delgado, Pello Sánchez, Begoña Porras, Irene Gimeno, Sergio González, Fernando Benito-Lopez, Lourdes Basabe-Desmonts, Mikel Sánchez\",\"doi\":\"10.1155/2024/6444120\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Nowadays, biological therapies are booming and more of these formulations are coming to the market. Platelet-rich plasma, or PRP, is one of the most widely used biological therapies due to its ease of obtention and autologous character. Most of the techniques to obtain PRP are focusing on new processes and methods of optimization. However, not enough consideration is being given to modify the molecular components of PRP to generate more effective formulations with the aim of improving PRP treatments. Therefore, this review covers different novel PRP-obtaining methods that attempt to modify the molecular composition of the plasma.\",\"PeriodicalId\":9007,\"journal\":{\"name\":\"BioMed Research International\",\"volume\":\"2024 \",\"pages\":\"6444120\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2024-08-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11329313/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BioMed Research International\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1155/2024/6444120\",\"RegionNum\":3,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BioMed Research International","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1155/2024/6444120","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

如今，生物疗法正在蓬勃发展，越来越多的生物制剂出现在市场上。富血小板血浆（PRP）因其易于获取和自体特性而成为最广泛使用的生物疗法之一。获取 PRP 的大多数技术都集中在新工艺和优化方法上。然而，对于如何改变 PRP 的分子成分以产生更有效的制剂，从而改进 PRP 治疗，目前考虑得还不够。因此，本综述涵盖了试图改变血浆分子成分的各种新型 PRP 获取方法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Current Challenges in the Development of Platelet-Rich Plasma-Based Therapies.

Nowadays, biological therapies are booming and more of these formulations are coming to the market. Platelet-rich plasma, or PRP, is one of the most widely used biological therapies due to its ease of obtention and autologous character. Most of the techniques to obtain PRP are focusing on new processes and methods of optimization. However, not enough consideration is being given to modify the molecular components of PRP to generate more effective formulations with the aim of improving PRP treatments. Therefore, this review covers different novel PRP-obtaining methods that attempt to modify the molecular composition of the plasma.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

BioMed Research International BIOTECHNOLOGY & APPLIED MICROBIOLOGY-MEDICINE, RESEARCH & EXPERIMENTAL

CiteScore

6.70

自引率

0.00%

发文量

1942

审稿时长

19 weeks

期刊介绍： BioMed Research International is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies covering a wide range of subjects in life sciences and medicine. The journal is divided into 55 subject areas.